Keros Therapeutics
Alpna Seth has served as a member of the board of directors since May 2023. Dr. Seth was most recently the President and Chief Executive Officer of Nura Bio Inc. Previously, she was the Chief Operating Officer of Vir Biotechnology, Inc. and the Senior Vice President and Global Head of the Biosimilars business for Biogen, Inc. Dr. Seth currently serves on the board of directors of Bio-Techne Corporation and Seagen Inc. Dr. Seth received a Ph.D. in biochemistry and molecular biology from University of Massachusetts Medical School and conducted her post-doctoral research at Harvard University in immunology and structural biology, both as a Howard Hughes Medical Institute Fellow. She is also a graduate of the Advanced Management Program at Harvard Business School.
This person is not in the org chart
This person is not in any offices
Keros Therapeutics
2 followers
Keros is dedicated to discovery and development of novel therapeutics for hematological and musculoskeletal disorders.